Measuring cytokine levels in blood: Importance of anticoagulants, processing, and storage conditions

作者: P.W. Thavasu , S. Longhurst , S.P. Joel , M.L. Slevin , F.R. Balkwill

DOI: 10.1016/0022-1759(92)90313-I

关键词: Serum samplesQuantitative analysis (chemistry)Recombinant CytokinesAnticoagulantWhole bloodMedicineChromatographyHeparinCytokineImmunologySignificant difference

摘要: The stability and recovery of six human recombinant cytokines (tumour necrosis factor (TNF), interferon-alpha (IFN-alpha), IFN-gamma, interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-6) from whole blood was investigated with a view to optimizing collection storage procedures prior performing immunoassays. Blood healthy volunteers subjected various processing procedures. samples were treated either: ethylenediamine tetraacetic acid (EDTA) (1.5 mg/ml blood) (E); EDTA/Trasylol mg 1000 KIU/ml (ET); heparin (30 IU/ml) (H) or allowed clot (serum). bloods spiked individual cytokines, split into aliquots kept at 4 degrees C RT. In the first instance (n = 5 per cytokine) processed using sterile non-pyrogenic materials At regular time intervals, cold spun, separated, flash frozen assayed for appropriate cytokine RIA/IRMA methods. further study, timed separation repeated normal commercially available third 3 under conditions, aliquoted within half hour collection. These then cycles freeze thawing RT before assaying. general, in improved by and/or rapid separation. There no significant difference between handled sterile, conditions those collected described this paper did not induce any unspiked blood. Overall, EDTA-treated performed most consistently. addition trasylol significantly affect results. Most appeared unaffected up three thaw cycles. varied least stable as follows; TNF-alpha less than IL-6 IFN-gamma IFN-alpha beta. heparinized plasma considerably higher other serum samples. consistently lower amounts recovered (anticoagulant treated).(ABSTRACT TRUNCATED AT 400 WORDS)

参考文章(9)
I. Engelberts, W. A. Buurman, A. Moller, G. J. M. Schoen, C. J. Van Der Linden, Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine and cytokine research. ,vol. 10, pp. 69- 76 ,(1991)
Stefan Endres, Reza Ghorbani, Gerhard Lonnemann, Jos W.M. van der Meer, Charles A. Dinarello, Measurement of immunoreactive interleukin-1β from human mononuclear cells: Optimization of recovery, intrasubject consistency, and comparison with interleukin-1α and tumor necrosis factor Clinical Immunology and Immunopathology. ,vol. 49, pp. 424- 438 ,(1988) , 10.1016/0090-1229(88)90130-4
D.W. Miles, S.J. Longhurst, P.G. Harper, F.R. Balkwill, Toxicity and reconstitution of recombinant interleukin-2 with albumin. The Lancet. ,vol. 338, pp. 1464- 1464 ,(1991) , 10.1016/0140-6736(91)92770-3
S. Poole, A.F. Bristow, S. Selkirk, B. Rafferty, Development and application of radioimmunoassays for interleukin-1α and interleukin-1β Journal of Immunological Methods. ,vol. 116, pp. 259- 264 ,(1989) , 10.1016/0022-1759(89)90212-3
R. Freeman, J. Wheeler, H. Robertson, M.L. Paes, J. Laidler, In-vitro production of TNF-α in blood samples The Lancet. ,vol. 336, pp. 312- 313 ,(1990) , 10.1016/0140-6736(90)91848-5
Mikael Lantz, Saleem Malik, Maurive L. Slevin, Inge Olsson, Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans Cytokine. ,vol. 2, pp. 402- 406 ,(1990) , 10.1016/1043-4666(90)90048-X
P. Jeremy Mclaughlin, HelenM. Davies, Atsushi Aikawa, J.S. Elborn, F.M. Delamere, D.J. Shale, Tumour-necrosis factor in normal plasma The Lancet. ,vol. 336, pp. 1014- 1015 ,(1990) , 10.1016/0140-6736(90)92482-W
G Leroux-Roels, F Offner, J Philippé, A Vermeulen, Influence of blood-collecting systems on concentrations of tumor necrosis factor in serum and plasma. Clinical Chemistry. ,vol. 34, pp. 2373- 2374 ,(1988) , 10.1093/CLINCHEM/34.11.2373